tol1 Posted February 10, 2018 Share Posted February 10, 2018 The name has popped up multiple times on my screens and the stock has lost 1/3 LTM. Shire is a £28bn MC biotech company focused on rare diseases and trades at 7.9x '18 P/E. This is an industry I am not very familiar with, so I wanted to kick off the discussion. SHP merged with Baxalta mid-2016 and the deal (economics) have been critized at the time. Keen to hear why the stock trades where it does. Link to comment Share on other sites More sharing options...
tol1 Posted April 24, 2018 Author Share Posted April 24, 2018 Takeda, a Japanese pharma company led by a French CEO, has bid 5 times for Shire by now. Anyone who has been invested prior to the approach? Keen to share thoughts. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now